I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Düll, Johannes
19
results:
Search for persons
X
Format
Online (19)
Mediatypes
Articles (Online) (7)
OpenAccess-fulltext (11)
Thesis (Online) (1)
Languages
german (2)
english (17)
Sorted by: Relevance
Sorted by: Year
?
1
Th17.1 cell driven sarcoidosis-like inflammation after anti..:
Leipold, Alexander M.
;
Werner, Rudolf A.
;
Düll, Johannes
...
Leukemia. 37 (2023) 3 - p. 650-658 , 2023
Link:
https://doi.org/10.1038/..
?
2
Targeting CD19 in diffuse large B‐cell lymphoma: An expert ..:
Bailly, Sarah
;
Cartron, Guillaume
;
Chaganti, Sridhar
...
Hematological Oncology. 40 (2022) 4 - p. 505-517 , 2022
Link:
https://doi.org/10.1002/..
?
3
CD52 and OXPHOS—potential targets in ibrutinib-treated mant..:
Fuhr, Viktoria
;
Heidenreich, Shanice
;
Srivastava, Mugdha
...
Cell Death Discovery. 8 (2022) 1 - p. , 2022
Link:
https://doi.org/10.1038/..
?
4
The use of tafasitamab in diffuse large B-cell lymphoma:
Düll, Johannes
;
Topp, Max
;
Salles, Gilles
Therapeutic Advances in Hematology. 12 (2021) - p. 204062072110274 , 2021
Link:
https://doi.org/10.1177/..
?
5
Obinutuzumab and venetoclax induced complete remission in a..:
Zhou, Xiang
;
Steinhardt, Maximilian Johannes
;
Düll, Johannes
...
European Journal of Haematology. 104 (2020) 4 - p. 352-355 , 2020
Link:
https://doi.org/10.1111/..
?
6
Trade-off designs and comparative exergy evaluation of soli..:
Wang, Ligang
;
Düll, Johannes
;
Maréchal, François
.
International Journal of Hydrogen Energy. 44 (2019) 19 - p. 9529-9543 , 2019
Link:
https://doi.org/10.1016/..
?
7
Outcome of patients with relapsed/refractory acute lymphobl..:
Jabbour, Elias
;
Düll, Johannes
;
Yilmaz, Musa
...
American Journal of Hematology. 93 (2017) 3 - p. 371-374 , 2017
Link:
https://doi.org/10.1002/..
?
8
Th17.1 cell driven sarcoidosis-like inflammation after anti..:
Leipold, Alexander M
;
Werner, Rudolf A
;
Düll, Johannes
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9888347/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
9
CD52 and OXPHOS-potential targets in ibrutinib-treated mant..:
Fuhr, Viktoria
;
Heidenreich, Shanice
;
Srivastava, Mugdha
...
https://opus.bibliothek.uni-wuerzburg.de/frontdoor/index/index/docId/30081. , 2022
Link:
https://opus.bibliothek...
?
10
Targeting CD19 in diffuse large B-cell lymphoma: An expert ..:
Bailly, Sarah
;
Cartron, Guillaume
;
Chaganti, Sridhar
...
boreal:263829. , 2022
Link:
http://hdl.handle.net/20..
?
11
Targeting CD19 in diffuse large B-cell lymphoma : An expert..:
Bailly, Sarah
;
Cartron, Guillaume
;
Chaganti, Sridhar
...
Hematological Oncology. , 2022
Link:
https://ddd.uab.cat/reco..
?
12
Targeting CD19 in diffuse large B-cell lymphoma: An expert ..:
Bailly, Sarah
;
Cartron, Guillaume
;
Chaganti, Sridhar
...
boreal:263829. , 2022
Link:
http://hdl.handle.net/20..
?
13
CD52 and OXPHOS—potential targets in ibrutinib-treated mant..:
Fuhr, Viktoria
;
Heidenreich, Shanice
;
Srivastava, Mugdha
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805448/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
14
The use of tafasitamab in diffuse large B-cell lymphoma:
Düll, Johannes
;
Topp, Max
;
Salles, Gilles
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264734/. , 2021
Link:
http://www.ncbi.nlm.nih...
?
15
Polatuzumab vedotin as a salvage and bridging treatment in ..:
Liebers, Nora
;
Düll, Johannes
;
Fitzgerald, Donnacha
...
http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/62915. , 2021
Link:
http://publikationen.ub...
1-15